ATE487943T1 - Fluoreszenzpolypeptidkomplex einer grösse von 40 bis 500 nm - Google Patents

Fluoreszenzpolypeptidkomplex einer grösse von 40 bis 500 nm

Info

Publication number
ATE487943T1
ATE487943T1 AT05716540T AT05716540T ATE487943T1 AT E487943 T1 ATE487943 T1 AT E487943T1 AT 05716540 T AT05716540 T AT 05716540T AT 05716540 T AT05716540 T AT 05716540T AT E487943 T1 ATE487943 T1 AT E487943T1
Authority
AT
Austria
Prior art keywords
complex
size
polypeptide complex
fluorescent polypeptide
fluorescence
Prior art date
Application number
AT05716540T
Other languages
English (en)
Inventor
Albert Geiger
Peter Sluka
Alfons Nichtl
Hans Hornauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE487943T1 publication Critical patent/ATE487943T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/701—Integrated with dissimilar structures on a common substrate
    • Y10S977/702—Integrated with dissimilar structures on a common substrate having biological material component
    • Y10S977/705—Protein or peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
AT05716540T 2004-04-08 2005-04-06 Fluoreszenzpolypeptidkomplex einer grösse von 40 bis 500 nm ATE487943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04008587 2004-04-08
PCT/EP2005/003589 WO2005098436A1 (en) 2004-04-08 2005-04-06 A fluorescent polypeptide complex of 40 to 500 nm in size

Publications (1)

Publication Number Publication Date
ATE487943T1 true ATE487943T1 (de) 2010-11-15

Family

ID=34924572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05716540T ATE487943T1 (de) 2004-04-08 2005-04-06 Fluoreszenzpolypeptidkomplex einer grösse von 40 bis 500 nm

Country Status (6)

Country Link
US (1) US7662920B2 (de)
EP (1) EP1735617B1 (de)
AT (1) ATE487943T1 (de)
DE (1) DE602005024673D1 (de)
ES (1) ES2354436T3 (de)
WO (1) WO2005098436A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663935B2 (en) * 2008-12-12 2014-03-04 Beckman Coulter, Inc. Multicolor flow cytometry compositions containing unconjugated phycobiliproteins
US8877898B2 (en) 2010-04-30 2014-11-04 Stc.Unm Fluorescent fusion polypeptides and methods of use
WO2015065887A1 (en) * 2013-10-25 2015-05-07 Forelight, Llc Beverage additives and fermented beverages comprising a fluorescent protein
CN116047052B (zh) * 2022-11-10 2025-08-05 苏州优逸兰迪生物科技有限公司 一种别藻蓝蛋白荧光串联染料及其制备方法与偶联抗体的方法
CN116574271B (zh) * 2023-06-06 2023-12-19 苏州谱迪生物科技有限公司 一种用于免疫检测低丰度生物标志物信号级联放大的荧光树状大分子的制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169137A (en) * 1974-12-20 1979-09-25 Block Engineering, Inc. Antigen detecting reagents
JPS58222029A (ja) * 1982-06-21 1983-12-23 Dainippon Ink & Chem Inc フイコシアニンのイミドエステル架橋体およびその用途
US4542104A (en) * 1983-04-06 1985-09-17 The Board Of Trustees Of The Leland Stanford Jr. Univ. Phycobiliprotein fluorescent conjugates
US5171846A (en) 1990-05-21 1992-12-15 Coulter Corporation Method of preferential labelling of a phycobiliprotein with a second dye for use in a multiple color assay and product for such use
ES2112916T3 (es) 1991-10-15 1998-04-16 Multilyte Ltd Ensayo de union que utiliza un reactivo marcado.
US5661040A (en) * 1993-07-13 1997-08-26 Abbott Laboratories Fluorescent polymer labeled conjugates and intermediates
US5695990A (en) * 1995-04-10 1997-12-09 Cubicciotti; Roger S. Phycobilisomes, derivatives, and uses therefor
WO1998036099A1 (en) 1997-02-18 1998-08-20 Oncor, Inc. Detection of targets with green fluorescent protein and fluorescent variants thereof
US5891741A (en) * 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
US7256050B2 (en) 2000-06-16 2007-08-14 Martek Biosciences Corp. High fluorescent intensity cross-linked allophycocyanin

Also Published As

Publication number Publication date
US7662920B2 (en) 2010-02-16
DE602005024673D1 (de) 2010-12-23
EP1735617B1 (de) 2010-11-10
WO2005098436A1 (en) 2005-10-20
EP1735617A1 (de) 2006-12-27
US20070265430A1 (en) 2007-11-15
ES2354436T3 (es) 2011-03-15

Similar Documents

Publication Publication Date Title
ZA200702879B (en) Single domain antibodies against TNFR1 and methods of use therefor
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
DE60138927D1 (de) Menschlicher rezeptor für tumor necrosis factor
EP1553975A4 (de) Optimierte fc-varianten und herstellungsverfahren dafür
DE50114428D1 (de) Neue verwendung von kurzkettigen carbonsäuren
CY1106532T1 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
TR200400815T3 (tr) AtorvastatinÁyarı@kalsiyumunÁyeniÁkristalÁformlarıÁveÁbunlarınÁhazırlanmasıÁiçinÁişlemlerÁayrıcaÁdiğerÁformlarınÁhazırlanmasıÁiçinÁyeniÁişlemler
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
BR0306905A (pt) Vacinas de flavivìrus
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
WO2003050283A3 (en) A structure for presenting desired peptide sequences
WO2006134190A3 (es) Agentes y métodos basados en el uso del dominio eda de la fibronectina
ATE357967T1 (de) Emulsionen mit oberflächenmodifizierten organischen molekülen
DE602005024673D1 (de) Fluoreszenzpolypeptidkomplex einer grösse von 40 bis 500 nm
CA2529001A1 (en) Binding peptides: methods for their generation and use
DE502004010328D1 (de) Hydrogelhaltiges kompositmaterial, hergestellt durch elektrisch-ausgelöste präzipitation einer festphase
DE10108995A1 (de) Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren
DK1037642T3 (da) Modificerede polysaccharider med ændret biologisk genkendelse
DE60230822D1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
ATE402827T1 (de) Sicherheitselemente mit durch energieeintrag aktivierbaren eigenschaften
BRPI0406466A (pt) Composição oral e uso de perlita
FI20020600A0 (fi) Harava
ATE335766T1 (de) Antikörper gegen caspase-8, ihre herstellung und verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1735617

Country of ref document: EP